Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

March

Joel A. Smithers, D.O.; Decision and Order (March 18, 2019)

William A. Sanpablo, M.D.; Decision and Order (March 18, 2019)

Sharp (Bethlehem), LLC (March 18, 2019)

Importer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Patheon Pharmaceuticals, Inc. (March 6, 2019)

S&B Pharma Inc. (March 6, 2019)

Siegfried USA, LLC (March 1, 2019)

Meridian Medical Technologies (March 1, 2019)


February

30-Day Notice: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 (February 27, 2019)

Proposed Rule: New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222) (February 21, 2019)

Ajay S. Ahuja, M.D.; Decision and Order (February 21, 2019)

Importer of Controlled Substances Registration (February 21, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 21, 2019)

Importer of Controlled Substances Registration (February 21, 2019)

Importer of Controlled Substances Registration (February 21, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 21, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 21, 2019)

Importer of Controlled Substances Registration (February 21, 2019)

Johnson Matthey, Inc. (February 21, 2019)

Navinta LLC (February 21, 2019)

Noramco, Inc. (February 21, 2019)

Stepan Company (February 21, 2019)

Research Triangle Institute (February 21, 2019)

Curium US, LLC (February 20, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 11, 2019)

Robert T. Perez, M.D.; Decision and Order (February 11, 2019)

Miles J. Nelson, M.D.; Decision and Order (February 11, 2019)

Paul Surinder Singh, D.O.; Decision And Order (February 11, 2019)

PerkinElmer, Inc. (February 11, 2019)

Stepan Company (February 11, 2019)

Almac Clinical Services Incorp (ACSI) (February 11, 2019)

Importer of Controlled Substances Registration (February 7, 2019)

Importer of Controlled Substances Registration (February 7, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)

Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)

IsoSciences, LLC (February 7, 2019)

Kinetochem, LLC (February 7, 2019)

Johnson Matthey Pharmaceutical Materials, Inc. (February 7, 2019)

Research Triangle Institute (February 7, 2019)

Microgenics Corporation Thermo Fisher Scientific (February 7, 2019)

Chattem Chemicals (February 7, 2019)

Kurt L. Pflieger, M.D.; Order Dismissing Order To Show Cause (February 7, 2019)

Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction (February 7, 2019)


January 2019

Placement of MAB-CHMINACA in Schedule I (January 29, 2019)


December 2018

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2019 (December 28, 2018)

Notice of Intent: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I (December 28, 2018)

Importer of Controlled Substances Registration (December 27, 2018)

Importer of Controlled Substances Registration (December 27, 2018)

Stephen R. Kovacs, D.O.; Decision and Order (December 27, 2018)

Johnson Matthey Inc. (December 27, 2018)

Myoderm (December 27, 2018)

Agilent Technologies (December 27, 2018)

Usona Institute (December 14, 2018)

Arizona Department of Corrections (December 14, 2018)

Usona Institute (December 14, 2018)

Eli-Elsohly Laboratories (December 13, 2018)

Cambrex High Point, Inc. (December 13, 2018)

Siegfried USA, LLC (December 13, 2018)

Mylan Pharmaceuticals Inc. (December 13, 2018)

Noramco Inc. (December 13, 2018)

Mylan Technologies, Inc. (December 13, 2018)

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018 (December 10, 2018)

Bulk Manufacturer of Controlled Substances Registration (December 6, 2018)

Decision and Order: Zelideh I. Cordova-Velazco, M.D. (December 6, 2018)

Exempt Chemical Preparations Under the Controlled Substances Act (December 3, 2018)


November

Steve Fanto, M.D.; Decision and Order (November 30, 2018)

Narciso A. Reyes, M.D.; Decision and Order (November 30, 2018)

Final Order: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I (November 29, 2018)

Importer of Controlled Substances Registration (November 27, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 27, 2018)

Importer of Controlled Substances Registration (November 27, 2018)

Noramco Inc. (November 27, 2018)

Insys Manufacturing, LLC (November 27, 2018)

Cayman Chemical Company (November 27, 2018)

Akorn, Inc. (November 27, 2018)

Cambridge Isotope Laboratories (November 27, 2018)

GE Healthcare (November 27, 2018)

Fisher Clinical Services, Inc. (November 27, 2018)

Sigma Aldrich Co., LLC (November 27, 2018)

Organix, Inc. (November 20, 2018)

Patheon API Manufacturing, Inc. (November 20, 2018)

Edward A. Ridgill, M.D.; Decision and Order (November 20, 2018)

Eldor Brish, M.D.; Decision and Order (November 20, 2018)

Lipomed (November 20, 2018)

Janssen Pharmaceuticals Inc. (November 20, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 9, 2018)

Chattem Chemicals (November 9, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 2, 2018)

Janssen Pharmaceuticals, Inc. (November 2, 2018)


October

Importer of Controlled Substances Registration (October 30, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 30, 2018)

Insys Manufacturing, LLC (October 30, 2018)

Sigma Aldrich Research (October 30, 2018)

Eric Lee Knight, M.D.; Decision and Order (October 30, 2018)

Cambrex High Point, Inc. (October 30, 2018)

United States Pharmacopeial Convention (October 30, 2018)

Sharp (Bethlehem), LLC (October 30, 2018)

Fisher Clinical Services, Inc. (October 30, 2018)

Catalent CTS, LLC (October 30, 2018)

Hisham M. Shawish, M.D.; Decision and Order (October 25, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 19, 2018)

Importer of Controlled Substances Registration (October 19, 2018)

Noramco Inc. (October 19, 2018)

Fisher Clinical Services, Inc. (October 19, 2018)

Importer of Controlled Substances Registration (October 15, 2018)

Specgx, LLC (October 15, 2018)

Phillip O. Rawlings, Jr., M.D.; Decision and Order (October 15, 2018)

Cambrex High Point, Inc. (October 15, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 2, 2018)

Importer of Controlled Substances Registration (October 2, 2018)

Importer of Controlled Substances Registration (October 2, 2018)

Rhodes Technologies (Correction) (October 2, 2018)

AMPAC Fine Chemicals, LLC (October 2, 2018)

Cambrex Charles City (October 2, 2018)

R & D Systems, Inc. (October 2, 2018)

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility